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A novel receptor-type protein tyrosine phosphatase with a single catalytic 
domain is specifically expressed in mouse brain
Wiljan HENDRIKS,* Jan SCHEPENS, Curt BRUGMAN, Patrick ZEEUWEN and Bé WIERINGA
Department of Cell Biology and Histology, University of Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
Protein tyrosine phosphatases (PTPases) are important regu- PTPases, whereas the third originates from a large-sized mRNA 
la tory proteins that, together with protein tyrosine kinases, deter- that is more ubiquitously expressed. A full-length cDNA en- 
mme the phosphotyrosine levels in cell signalling proteins. By coding one of the brain-specific PTPases, PTP-SL, was isolated. 
PCR amplification of mouse brain cDNA fragments encoding the Sequence analysis revealed a transmembrane PTPase containing a
catalytic domains of these enzymes, we identified three novel single catalytic phosphatase domain that has 45 % homology to a
members of the PTPase gene family. Northern-blot analysis rat cytoplasmic brain-specific PTPase named STEP. This suggests 
showed that two of these novel clones represent brain-specific a role for PTP-SL in cell-cell signalling processes in the brain.
INTRODUCTION
Protein phosphorylation, the transfer of phosphoryl groups from 
ATP on intracellular proteins, is recognized as a key event in the 
transduction of extracellular signals [1,2]. Subsequent removal of 
phosphoryl groups from target proteins by protein phosphatases 
has long been considered a housekeeping process without any 
regulatory role in cell signalling. However, for many different 
organisms, such as Yersinia [3], yeast [4], Dktyostelium [5,6], 
Drosophila [7] and mouse [8,9], recent experiments have now 
revealed important roles for protein tyrosine phosphatases 
(PTPases) in the regulation of development and cellular pro­
liferation. As a consequence, it has now become clear that the 
interplay of kinases and phosphatases is crucial for actuating 
cellular responses to extracellular signals. Structural information 
on PTPases has accumulated rapidly over the last few years, and 
many have been found to be transmembrane receptor-type 
molecules [10-12]. These enzymes thus represent a novel rep-
20 mM Tris/HCl (pH 8.4), 50 mM KC1, 2.5 mM MgCl2, 0.01 %
BSA, all four dNTPs (each at 250 /¿M), 2 units of Taq polymerase 
(Perkin-Elmer Cetus) and 10 ng of phage DNA. Thirty-five 
cycles were performed on a Perkin-Elmer thermal cycler; each 
cycle involved incubation at 94 °C for 0.5 min, at 37 °C for 0.5 
min and at 72 °C for 1 min. The PCR products were treated with 
proteinase K as described previously [13]. After DNA end-repair 
using Klenow (large fragment) DNA polymerase, the fragments 
were 5'-phosphorylated with T4 polynucletoide kinase and ATP, 
and analysed on a 1.5% low-gelling-temperature agarose gel. 
Fragments of 350-400 bp were excised and subcloned into the 
Smal site of plasmid pBlueScript by standard protocols [14]. 
Sequences were determined using the double-stranded DNA 
dideoxy sequencing method [15].
Isolation and sequencing of mPTP13 cDNAs
ertoire of signalling proteins the precise role of which in cell The mPTP 13 PCR fragment was isolated, labelled radioactively
physiology, growth control and pathogenesis still has to be by random priming [16], and used to screen a mouse brain À-
determined. ZAPII cDNA phage library (Stratagene). Hybridization con-
To obtain the molecular tools for further study of the ditions were those of Church and Gilbert [17]: membranes were
bioactivity of PTPases in mouse development, we have cloned preincubated in hybridization buffer [7 % SDS, 0.5 M sodium
several PTPase sequences from murine brain employing de- phosphate buffer (pH 7.4), 1 mM EDTA] for 10-60 min at
generate oligonucleotide primers and PCR techniques. A novel 65 °C. After probe dénaturation and addition, membranes were
PTPase (PTP-SL) was found and its full-length cDNA was hybridized overnight at 65 °C. Washing at high stringency [0.1 %
isolated and characterized. M
MATERIALS AND METHODS 
PCR and subcloning of PTPase domains
was performed three times at 65 °C for 20 min. Autoradiography 
was on Kodak X-Omat SI films at —70 °C for 1-2 days using 
Dupont Cronex intensifying screens. Positive phages were 
plaque-purified and inserts were rescued as pBlueScript SK
Degenerate oligonucleotide primers 1 and 2 were based on plasmids according to the manufacturer’s protocols. Nucleotide 
consensus sequences for highly conserved amino acid stretches sequences were determined using the DNAase shotgun strategy 
within the catalytic domains in PTPases: primer 1, 5'- [18] in combination with the double-stranded DNA dideoxy
GA(C/T)TT(C/T)TGG(A/C)(A/G/T)(A/G)ATG(A/G)T(A/ sequencing method [15]. DNA sequence gel readings were
C/T)TGG(G/C)A-3'; primer 2, 5'-C(G/T)CCC(A/T)(A/G)- recorded, compared, edited and assembled using the IG-SUITE 
C( A /  G  /  C /  T)CC( A /  T)GC( A /  G /  C /  T)CT( A /  G)C AGTG - 3'. Mountain
DNA of a mouse brain cDNA phage library (Stratagene) was Deduced protein sequences were analysed using the GCG
used as a template for PCR. Primers 1 and 2 (final concentration
7 ng///l) were added to a 100 iá reaction mixture containing
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Receptor-type protein tyrosine phosphatase with single catalytic domain 501
mined as described by Bradford [23]. Lysate supernatants 
containing glutathione S-transferase (GST) or GST-SL fusion 
protein were used to determine tyrosine phosphatase activity 
with the colorimetric substrate ;?-nitrophenyl phosphate. 
Reactions were performed with lysate amounts and substrate 
concentrations that showed a linear reaction velocity with respect 
to time. Each 200 //I of reaction mixture contained 50 mM 
imidazole, pH 7.0, 5 mM /M iitrophenyl phosphate, 10 mM 
dithiothreitol, 10 mM EDTA and 0.5 /ig of protein. Potential 
modifiers of phosphatase activity were added to some reaction 
mixtures. Reaction mixtures were incubated for 30 min at 
37 °C and the reaction was terminated by adding 800 /<1 o f  
0.2 M NaOH. Absorbance was measured at 410 nm. Two 
phosphotyrosine-containing peptides were also used in a non- 
•adioactive phosphatase assay carried out as described by the
(a) 
28 S
18 S 
(b)
28 S
18 S
I 28 S
M
In vitro translation
The mPTPl3-6 cDNA clone was linearized with Xiiol and used 
for in vitro transcription with T3 RNA polymerase (Pharmacia) 
according to the manufacturer’s protocols. RNA (200 ng) was 
heated for 10 min at 67 °C and added to a rabbit reticulocyte 
lysate (Promega) for in vitro translation in the presence or 
absence of canine pancreatic microsomal membranes (Promega) 
as described by the manufacturer. The [8SS]methionine-labelled 
products were analysed by SDS/PAGE on a 10% polyacryl­
amide gel [24] and visualized, after treatment with dimethyl 
sulphoxide/2,5-diphenyloxazole and drying of the gel, by auto­
radiography on Kodak X-Omat SI film for 16 h.
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RESULTS
Cloning of three novel PTPase cDNA fragments
To isolate murine cDNA clones encoding PTPases, we designed 
denerate oligonucleotide primers based on sequences conserved 
in the core region of the catalytic phosphatase domain of most 
known PTPases. Using mouse brain cDNA as template, 29 
clones with PTPase domain-like inserts, grouped into 13 different
18 S
1
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Figure 2 Northern-blot analysis of mPTP13, mPTP14 and mPTP38 mRNA
Poly(A)+ RNA samples from adult mouse brain (lane 1), skeletal muscle (lane 2), heart (lane
sequences, were identified (Figure 1). Computer-assisted com- 3), spleen (lane 4), pancreas (lane 5), liver (lane 6), lung (lane 7) and kidney (lane 8), as well
parison with published PTPase domain sequences was performed as from a Balb/c mouse keratinocyte cell line (lane 9) and 13-day mouse embryos (lane 10)
were loaded. The cDNA fragments mPTP13 (a), mPTP14 (b) and mPTP38 (c) were used as 
probes (Figure 1). (d) Ethidlum bromide-staining pattern of the RNA gel. The 28S and 18S 
ribosomal bands, corresponding to 4.6 and 1.9 kb transcript lengths respectively, are indicated.
to reveal the possible identity of the clones. Five sequences 
(mPTPlB, mLRP-1 and -2, mPTPó'-l and mPTPe-1) contained 
regions that were identical with reported murine PTPases [27-31].
Five sequences (mLAR-l, mLAR-2, mBPTP-1, tnPTP/y and 
mPTPiv-2) probably represent mouse homologues of human or
rat PTPases [32 39] for which no mouse clones have been ization patterns for both probes (results not shown), indicating 
identified until now. Finally and most interestingly, three clones that the two PCR fragments indeed represent independent
with only weak homology to currently published phosphatase members of the PTPase family,
domains were found: mPTP13, mPTP14 and mPTP38. Still, the In contrast, mPTP14 is more
deduced protein sequences for these three clones clearly display corresponding to an mRNA size of around 8 kb are found in
the consensus features of tyrosine phosphatase domains (Figure RNA isolated from 13.5-day embryos and brain, muscle, heart 
1). We
PTPase family members.
Weak
:ind kidney of adult mice. A very strong signal was obtained 
using murine keratinocyte RNA (Figure 2b). Sequence com- 
To investigate the nature and expression patterns of the parison showed the highest homology for mPTP14 with the
transcripts from which these three novel PTPase cDNA fragments MEG ° //O and 31 % identity
originate, PCR fragments were used as probes on Northern blots respectively). MEG and PTPH1 contain one catalytic
containing RNA samples of various murine tissues. The mPTPl 3 phosphatase domain and an N-terminal stretch with significant
probe hybridized to mRNA species of 4.1 and 3.2 kb in adult similarity to band 4.1, ezrin and talin. This class of proteins is
brain. A very weak signal of the 4.1 kb mRNA was detectable in thought to mediate interactions between integral plasma-mem-
13.5-day embryos (Figure 2a). Also mPTP38 is exclusively brane proteins and the cytoskeleton [44]. However, the length of
expressed in brain, and originates from a single 4 kb mRNA the mPTPl4 transcript (8 kb) is significantly larger that those 
species (Figure 2c). No hybridizing signal could be obtained with (4-4
RNA isolated from 13.5-day embryos. Southern blots from m o d a te s a  m u ch  larger protein product. Isolation and elucidation 
different digests of murine genomic DNA yield distinct hybrid- of the full-length PTP14 cDNA sequence is needed to reveal the
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1 GCTAGCTCCA GGTGACTAAA CGAGGCTTCA GCTCGCAGGC TTTCTGATTA GCCCAGCTAG CAATGGTAAG GGAGTAACAA GAAGAACACA GATGGAAGTC GG
1
103 ATGCATCGCAACACTCGGTCAGTTTCCACA CCGACACTGCAAATGGATATAACCAAGCTG AACATAACCCTGCTTCGGATCTTCCGCCAA GGAGTAGCTGCAGCCCTGGGACTCTTACCT 
1 M H R N T R S V S T  P T L Q M D I T K L  N I I T L L R I F R Q  G V A A A L ’
Si  g---------------------------r
G L L P
223 CAGCAAGTGCACATTAACCGGCTCATTGAA AAGAAGAACCAGGTTGAGTTGTTTGTGTCT CCCGGAAACCGGAAACCAGGAGAAACGCAG GCCCTGCAGGCTGAGGAAGTGCTGCGTTCC 
4 1 Q Q V H I N R L I E  K K N Q V E L F V S  P G N R K P G E T Q  A L Q A E E V L R S
343  CTCAATGTGGATGGTTTGCATCAGAGTTTA CCACAGTTTGGAATTACAGACTGCGCCCCT GAGAAAAATGT TT T ACAAGGGCAGCACGAA GCAGACAAGATCTGGAGCAAAGAAGGATTT 
81 L N V D G L H Q S L  P Q F G I T D C A P  E K N V L Q G Q H E  A D K I W S K E G l F
--------------------  - | [ -  - -  -  ----------------------- - -  -  ----------------------  -------------------- --------------------—  ..............■ ■  - I  ! ■  I I I . .  ■ I I ........................ .... ■ »  I ....................................... " j  ^
463 TACGCTGTCGTCATCTTCCTCAGCATCTTT ATCATCATACTAACCTGTTTGATGATTATT TACAGGTTAAAAGAAAGGCTTCAGCTTTCC TTAAGACAAGATAAAGAGAAAAACCAGGAG 
121 Y A V V I F L S I F ' I I I V T C L M I  I Y R L K E R L Q L S  L R Q D K E K N Q E
TM
583 ATCCACCTATCACCCATTGCACGGCAGCAA GCACAATCGGAGGCCAAGACGACCCACAGC ATGGTCCAGCCCGATCAGGCGCCAAAGGTG CTGAACGTGGTTGTGGACCCTCAAGGCCAA
161 I H L S P I A R Q Q  A Q S E A K T T H S  M V Q P D Q A P K V  L N V V V D P Q G G
703 TGCACTCCTGAGATTCGAAACAGCACCTCC ACCTCTGTCTGCCCTTCTCCCTTCAGAATG AAGCCCATAGGACTCCAGGAGCGACGAGGT TCCAATGTATCTCTTACGCTGGACATGAGT
201 C T P E  I R N S T S  T S V C P S P F R M  K P I G L Q E R R G  S N V S L T L D M S
823  AGCCTGGGCAGTGTGGAACCCTTTGTGGCC GTCTCAACCCCCCGGGAGAAGGTAGCCATG GAATACCTGCAGTCAGCCAGCCGAGTTCTC ACACGGTCACAGCTGAGGGACGTCGTGGCA
2 4 1 S L G S V E P F V A  V S T P R E K V A M  E Y L Q S A S R V L  T R S Q L R O V V A
943 AGTTCCCACCTACTTCAAAGTGAATTCATG GAAATACCAATGAATTTTGTGGATCCCAAA GAAATTGATATTCCACGTCACGGAACTAAA AATCGTTATAAGACCATTTTGCCAAATCCC
2 8 1 S S H L L Q S E F M  E I P M N F V D P K  E 1 D I P R H G T K  N R Y K T I L P N P
1063 CTCAGCAGAGTGTGCTTAAGACCAAAAAAT ATAACCGATTCCTTGAGTACTTACATAAAT GCTAACTATATTCGGGGCTACAGTGGTAAG GAGAAAGCCTTCATTGCCACCCAGGGCCCC
321 L S R V C L R P K N  I T O S L S T Y  I N A N Y  I R G Y S G K  E K A F 1 A T Q G P
1183 ATGATCAACACTGTGAATGACTTCTGGCAG
361 H I N T V N D F W Q  M V W Q E D S P V I  V M ! T K I K E K N  E K C V L Y W P E K
401 R G I Y G K V E V L  V T G V T E C D N Y  T I R N L V L K Q G  S H T Q H V K H Y W
1423
4 4 1 Y T S W P D H K T P  D S A Q P L L Q L M  L D V E E D R L A S  E G R G P V V V H C
1543 AGTGCGGGGATTGGGAGAACTGGGTGTTTC ATCGCTACATCCATTGGCTGTCAACAATTG AAAGAAGAAGGAGTTGTAGACGCACTAAGT ATTGTCTGCCAGCTTCGTGTAGACAGGGGT
G481 S A G I G R T G C F I A T S I G C Q Û L K E E G V V D A L S 3 V C Q L R V 0 R
1663
521
GGTATGGTCCAAACCAGCGAGCAGTATGAA TTTGTGCACCATGCTCTGTGCCTGTTCGAG AGCAGACTTTCACCAGAAACTGTCGAGTGA CTCCGAAG ATTTACCAGA 
G M V  Q T S E Q Y E  F V H H A L C L  F E S R L S P E T V E *
1771 GTGTCAATCT CTCACCGGGT GATTCATCAA ATTACCTACC AAGAGCTCCA AGAGGGGCTC CCTGCAATGG ACGAGGAGGC TCTAAAGCCA GCCTAAGGCA CTGATTGTGG
1881 AAGATCTGGC AACATGAAAG ATTGCCAGCC TTTGT GTATA GGACTGCGTT CGTAGGCATC CCCCCAGTTA TTCTGAAGGT CCTGTGCTGA TGGAGGCATG ACAGTCCTCT
1991 CGCAGCCTGA GGAGGGTTTT GTTCTGTCTG TGTCGCCTCT CCGCCGCACA GAATCGATGT GTGTGATATT CAGAGACTGG AGGAGCTGCT GACATTATCC TGTGTTTAGA
2101 TGCTTTAAT G TTCATAAAGC CTGTCTTGTG ACTGGACTGT CAGCTGTCCA ACTGTCCCTG TTGTAAGTGC TATTAACTAT CTCAGTTACC AGAATCTTGC TGCTCAAGTT
2211 TCGAGTGATC GACAATGGAT TTTTAACCAA GACATTTTTG TTTTTGGAAA AAAAAAAAAA ATCAAATGCA GTGACTATTT TATATGGACA TGTGTCTTGA TTATATCTAT
2321 TAAGTGTGCA TTATAGTATC TCCCTATGGG ATCAATTACA GAGCACAATG ACTGTCGGTT GGATATATAT GTATATGTAT ATGTATATTA TATGTATATG TACACATATA
2431 TATTCTATTA TTAGGCATAC AAGTGGCTCC TGTTCCACAA TACTAACTAC TATATTTCTA CATTGTGACT TGTTTTACTT TAAAAGGGGA TAAACAAATT TATAGCAACT
2541 ATAAAGTATC AATAATTTTA AATACTCATC TCTCTTTTAC TAAGAAGGGA TTTTTAAATA TGGTGTCTAC CTGGTATCTC TCTCCCAATA AGAAGCAGGT GCCTTTGGGG
2651 AATGCTCCAA CCTGTTTCAT CCCCAAAAGT T TTTCCGAGG ACACTGTCAT GCACGACCT C ACATTTCTAA AAGACCTCCT TCCTCAAGAG ACAAATGAAG GCAAAATAAT
2761 CACACT CAGC AAACAGGAGA TGTTCTGCTC AGATATGAAT TTTCAATGCA GCAAAGCTGA C7TT CTTTCG
1 1
TACTCCCAAT AAATGACTCT TAACAGTA
1— p A - J
Figure 3 Complete nucleotide sequence of mPTP13-6 and deduced amino acid sequence of PTP-SL
The asterisk indicates a stop codon. The four putative translation initiation codons discussed in the text and the preceding in-trame stop codons are underlined. The signal sequence (Sig),
transmembrane domain (TM) and poly(A)+ signal (pA) are indicated by open boxes. The arrow marks the putative cleavage site within the signal sequence. The sequence present in mPTP13 is 
shown on a shaded background.
addition, GLGF repeats.
nature of this novel PTPase. While this manuscript was in responding gene. To obtain full-length cDNA clones, a mouse 
preparation, Maekawa and co-workers [45] published a human brain cDNA library was screened with the PCR-derived mPTP 13 
sequence with close homology to mPTP14. They predict an open fragment as a probe. Eleven overlapping clones were obtained 
reading frame which contains a band-4.1-like domain and, in and the longest insert (2.9 kbp) present in clone PTP13-6 was ^ * ft - .- . . _._ ^
sequenced completely. All other clones were shown by end-in 
sequencing to represent shorter versions of the same transcript
Analysis of mPTP13 cDNA species. The nucleotide sequence and deduced amino acid se­
quence are shown in Figure 3. An open reading frame is found 
Northern-blot analysis had suggested the possibility of develop- that spans 549 residues and is preceded by several in-frame stop 
mentally regulated alternative splicing for the mPTP13 cor- codons. Therefore we conclude that mPTP13-6 represents a full-
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Table 1 Phosphotyrosine phosphatase activity of GST-SL fusion protein in 
the presence or absence of various potential inhibitors
All assays were performed in triplicate. An activity of 100% corresponds to an /I410 of 0.301 
after a 30 min incubation, as outlined in the Materials and methods section.
Protein Modifier
Activity
(% ol G S T -S L )
Figure 4 Analysis of PTP-SL in vitro translation products
PTP-SL mRNA, produced by in vitro transcription of mPTP13-6 using T3 RNA polymerase, was 
translated In a rabbit reticulocyte lysate in the presence of [35S]methlonine. Protein products 
were analysed by SDS/PAGE and visualized by autoradiography. Lane 1, PTP-SL; lane 2, 
luciferase as a control (61 kDa). Molecular-mass markers are indicated on the left.
GST <  1
GST-SL — 100
GST-SL 0.5 mM vanadate 40
GST-SL 2.5 mM vanadate 5
GST-SL 0.1 mM phenylarsine oxide 42
GST-SL 0.1 mM ZnCI2 96
GST-SL 1.0 mM ZnClg 9S
GST-SL 0.1 //,M okadaic acid 97
GST-SL 1,0 /(M  okadaic acid 102
length cDNA clone of the smaller (3.2 kb) transcript found in 
adult mouse brain. None of the other isolated mPTP13 clones 
seemed to represent cDNA copies of the larger transcript.
Comparison of the open reading frame in PTP13-6 with all 
currently available mammalian PTPase sequences shows closest 
resemblance (45% amino acid identity over the segment dis­
played in Figure 1) to the brain-specific rat PTPase STEP [46]. 
Therefore we propose the name PTP-SL (STEP-like PTPase) for 
the protein encoded by mPTP13-6. STEP is expressed within 
dopaminoceptive neurons of the basal ganglia and related 
structures and appears in three cytoplasmic isoforms of molecular 
mass 46, 37 and 33 kDa [47]. From analogy with the STEP 
protein, the methionine at position 181 (nt 643-645) could be the 
first amino acid residue of PTP-SL. Three other potential 
translation start sites are present upstream of this AUG codon in 
mPTP13-6 (Figure 3). In vitro translation of mPTP13-6-derived 
RNA revealed a protein with an apparent molecular mass of 
60 kDa (Figure 4), demonstrating that it is either the first 
(nt 103-105) or, more likely, the second (nt 145-147) AUG 
codon that is used as the translation start codon (resulting in 
62 and 60 kDa proteins respectively).
A single conserved tyrosine phosphatase catalytic domain, 
which contains the highly conserved sequence VHCXAGXXR, 
is found at the C-terminus of PTP-SL. To demonstrate that PTP- 
SL indeed has tyrosine phosphatase activity, a fragment encoding 
the last 294 residues was cloned into the bacterial expression
Computer analysis of the deduced PTP-SL protein sequence 
revealed a signal sequence and a hydrophobic transmembrane 
region, indicating that PTP-SL is a type-I transmembrane protein 
(Figure 3). To test whether the predicted signal sequence cleavage 
site [20] is used, an in vitro translation experiment was performed 
in the presence of pancreatic microsomes. Although the control 
protein (/?-lactamase) was correctly processed, no change in 
mobility could be observed for PTP-SL (results not shown). Also 
the use of a truncated version of PTP-SL, made by introducing 
a stop codon after residue 260, did not show altered mobility as 
a result of signal-peptide cleavage. We can therefore conclude 
that either the PTP-SL signal sequence is not normally cleaved or 
the specific endopeptidase involved is not present or active in the 
microsomal fraction used. Future experiments employing pep­
tide-specific antibodies will be necessary to reveal the precise 
processing and membrane orientation of PTP-SL.
DISCUSSION
Using degenerate oligodeoxynueieotides and PCR, probes were 
obtained for three novel putative PTPases. For one of these, 
mPTP13, Northern-blot analysis suggested developmental^ reg­
ulated alternative splicing of the corresponding brain-specific 
primary transcript. A full-length cDNA was subsequently iso­
lated from a mouse brain cDN A library, representing the smaller, 
3.2 kb, messenger and encoding PTP-SL. In embryonic tissue 
only the larger, 4.1 kb, mRNA species could be detected with the 
mPTPl 3 probe (Figure 2a). The length and terminal sequences o f 
the inserts from the different cDNA clones indicated that all 
originate from the shorter transcript. Using several different 
vector pGEX-2T [22]. The predicted 60 kDa recombinant GST cDNA fragments as probes on Northern blots of murine brain
fusion protein was detected on SDS/PAGE when transformed mRNA, we attempted to reveal internal sequence d¡(Terences
bacteria were grown in the presence of isopropyl thiogalactoside between the two transcripts. All probes, however, gave identical
(results not shown). The fusion protein was predominantly hybridization patterns (results not shown) making it very difficult
present in inclusion bodies, but still contributed to about 1 % of to speculate on the origin of the two hybridizing mRNA species.
the Triton X-100-soluble protein fraction. With p-nitrophenyl 
phosphate as substrate, the GST-SL fusion protein, but not GST 
alone, displayed significant phosphatase activity which appeared 
to be sensitive to known PTPase inhibitors such as van date and 
phenylarsine oxide [48]. PTP-SL activity was not inhibited by 
Zn2+ under the conditions used or by the serine/threonine 
phosphatase inhibitor okadaic acid (Table' 1). Furthermore 
two different phosphotyrosine-containing peptides could be 
dephosphorylated by the GST-SL fusion protein as determined 
using a non-radioactive assay (results not shown), clearly demon­
strating the phosphotyrosine phosphatase activity of PTP-SL.
They might result from the use of alternative promoters, differ­
ential splicing or polyadenylation, or the expression of recently 
duplicated genes. Southern-blot analysis of mouse genomic DNA 
digests reveals a rather simple hybridization pattern (results not 
shown) arguing against the latter possibility. Alternative splicing 
is a more likely explanation because this phenomenon has been 
previously demonstrated for many PTPase genes, interestingly, 
in rat brain samples, both a 4.4 kb and a more prominent 3 kb 
mRNA species are recognized by STEP-specific probes and these 
have been suggested to be the result of alternative splicing o f 
transcripts derived from a single gene [46], Clearly, a more
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detailed characterization of the PTP-SL gene structure or cloning 
of the larger mRNA species will be necessary to establish the 
precise relationships between the two transcripts.
From the mPTP13-6 cDNA sequence it can be deduced that 
PTP-SL is a transmembrane receptor-type PTPase containing 
one conserved phosphatase catalytic domain. This is a rather 
unusual conformation as single phosphatase domains are mainly 
restricted to cytoplasmic PTPases, receptor-type PTPases con­
sistently having two tandem repeated domains. Thus far, only 
two exceptions have been reported : the receptor-type PTPases 
HPTP/? [32] and PTP-PS [40]. PTP-PS lacks the second 
phosphatase domain that is present in PTP-P1 because of 
alternative splicing of a single precursor transcript. In the light of 
this, it will be interesting to investigate whether the 4.1 kb 
transcript encodes a PTP-SL isoform with two phosphatase 
domains. The extracellular portions of PTP-PS, PTP/? and PTP- 
SL are completely different. PTP-PS contains four fibronectin 
type-III repeats and three immunoglobulin-like domains. HPTP/? 
has eight fibronectin type-III repeats. In contrast, PTP-SL has a 
relatively short extracellular part (Figure 3) which displays no 
obvious similarities to other proteins.
Many receptor-type molecules, such as the cytokine receptors, 
have cytoplasmic portions that do not appear to contain domains 
with recognizable catalytic functions. These ligand-binding mole­
cules are thought to mediate the actual signalling effect via 
association, direct or indirect, with proteins that do contain such 
catalytic signalling functions [49]. PTP-SL has a rather short 
extracellular domain, like the transmembrane PTPases 
LRP/HPTPa and HPTPe [32], and perhaps lacks ligand-binding 
capability. It is tempting to speculate that PTP-SL may be a 
catalytic component of an as yet unknown complex in which 
other transmembrane proteins contribute this ligand-binding 
feature. Future experiments will be aimed at identification of 
proteins that associate with PTP-SL in order to unravel its role 
in the functioning and development of the brain.
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